Takeda Pharmaceutical Co Ltd
Change company Symbol lookup
Select an option...
TKPHF Takeda Pharmaceutical Co Ltd
QRTEA Qurate Retail Inc
SRRA Sierra Oncology Inc
ICPT Intercept Pharmaceuticals Inc
MO Altria Group Inc
AI C3.ai Inc
INUV Inuvo Inc
PZZA Papa John's International Inc
REVHU Revolution Healthcare Acquisition Corp
DORM Dorman Products Inc
Go


Based in Japan
Company profile

Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.

Price
Delayed
$29.42
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)

Today's volume of 0 shares is on pace to be much lighter than TKPHF's 10-day average volume of 121,162 shares.

0

Upcoming Events

TKPHF's fiscal year ends in March
There are no upcoming events for TKPHF

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
Earnings
estimate range
Previous year's
actual
May 11, 2022Q4 2022 Earnings Release-$0.064--$1.21
February 3, 2022Q3 2022 Earnings Release$0.329$0.712 to $0.712$0.558
October 28, 2021Q2 2022 Earnings Release$0.264--$0.024
July 30, 2021Q1 2022 Earnings Release$1.17$0.81 to $0.81$0.492

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.